Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews - PubMed (original) (raw)
Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews
R Collins et al. Stat Med. 1987 Apr-May.
Abstract
In order to avoid selective biases and to minimize random errors, inference about the effects of treatment on serious endpoints needs to be based not on one, or a few, of the available trial results, but on a systematic overview of the totality of the evidence from all the relevant unconfounded randomized trials. But, only where coverage of all, or nearly all, randomized patients in all relevant trials (or a reasonably unbiased sample of such trials) can be assured, is a systematic overview of trials reasonably trustworthy, for then any selective biases are likely to be small in comparison with any moderate effects of treatment. Checks for the existence of such biases can best be conducted if reasonably detailed data are available from each trial. Future trials should take into account the results of any relevant overviews in their design, and should plan to obtain sufficient numbers of events to contribute substantially to such overviews. In many cases, this implies the need for randomized trials that are much larger than is currently standard.
Similar articles
- Implications of overviews of randomized trials.
Hennekens CH, Buring JE, Hebert PR. Hennekens CH, et al. Stat Med. 1987 Apr-May;6(3):397-409. doi: 10.1002/sim.4780060337. Stat Med. 1987. PMID: 3616292 - Lessons from overviews of cardiovascular trials.
Furberg CD, Morgan TM. Furberg CD, et al. Stat Med. 1987 Apr-May;6(3):295-306. doi: 10.1002/sim.4780060316. Stat Med. 1987. PMID: 3616285 - Why do we need systematic overviews of randomized trials?
Peto R. Peto R. Stat Med. 1987 Apr-May;6(3):233-44. doi: 10.1002/sim.4780060306. Stat Med. 1987. PMID: 3616281 No abstract available. - Randomisation to protect against selection bias in healthcare trials.
Kunz R, Vist G, Oxman AD. Kunz R, et al. Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000012. doi: 10.1002/14651858.MR000012.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443633 Updated. Review. - Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG. Henderson JT, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
Cited by
- Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
Andras A, Stansby G, Hansrani M. Andras A, et al. Cochrane Database Syst Rev. 2013 Jul 19;2013(7):CD003285. doi: 10.1002/14651858.CD003285.pub2. Cochrane Database Syst Rev. 2013. PMID: 23881650 Free PMC article. Review. - Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
Collins R, Baigent C, Sandercock P, Peto R. Collins R, et al. BMJ. 1994 Nov 5;309(6963):1215-7. doi: 10.1136/bmj.309.6963.1215. BMJ. 1994. PMID: 7987156 Free PMC article. Review. No abstract available. - Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism.
Bhutia S, Wong PF. Bhutia S, et al. Cochrane Database Syst Rev. 2013 Jul 16;2013(7):CD003074. doi: 10.1002/14651858.CD003074.pub3. Cochrane Database Syst Rev. 2013. PMID: 23857562 Free PMC article. Review. - Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.
Teo KK, Yusuf S. Teo KK, et al. Drugs. 1993 Sep;46(3):347-359. doi: 10.2165/00003495-199346030-00002. Drugs. 1993. PMID: 7693427 Review. - Making trials part of good clinical care: lessons from the RECOVERY trial.
Pessoa-Amorim G, Campbell M, Fletcher L, Horby P, Landray M, Mafham M, Haynes R. Pessoa-Amorim G, et al. Future Healthc J. 2021 Jul;8(2):e243-e250. doi: 10.7861/fhj.2021-0083. Future Healthc J. 2021. PMID: 34286192 Free PMC article.
MeSH terms
LinkOut - more resources
Medical